ETF Education channelEconomics, Patents Critical for Pharmaceuticals Innovation, Equity PricesBy Tom LydonNovember 15, 2021
ETF Education channelBlue-Chip Pharmaceuticals Stocks Contend With Political HeadwindsBy Tom LydonSeptember 21, 2021
Innovative ETFs ChannelPotential Peanut Allergy Treatment Gives Pharma Company A BoostBy Ian YoungSeptember 11, 2019
Beyond Basic Beta Channel8 ETFs to Capture Opportunities in Healthcare SectorBy Max ChenAugust 22, 2019
Innovative ETFs ChannelAbbVie, Allergan Deal Puts Spotlight on Pharmaceutical ETFsBy Max ChenJune 25, 2019
Beyond Basic Beta Channel4 ETFs to Consider with Big Pharma on the Senate’s Hot SeatBy Ben HernandezApril 9, 2019
Innovative ETFs ChannelPharmaceutical ETFs Break Out on Horizon Pharma’s Positive Drug ResultsBy Max ChenFebruary 28, 2019
Equity ETFs6 Top Healthcare ETFs Rally as Trump Vows End to ‘Global Freeloading’By Max ChenMay 11, 2018
